Position in PBYI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,225,812
+$250,786 QoQ
Shares Held
191,833
+17.1% QoQ
Ownership
0.377%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $48,167,308,152 across 354 Biotechnology names. PBYI ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in PBYI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,225,812 | 191,833 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $975,026 | 163,870 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $771,463 | 145,285 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $454,007 | 132,364 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $376,434 | 127,174 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $402,142 | 131,850 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $301,575 | 118,265 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $303,447 | 93,082 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $485,957 | 91,690 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $242,800 | 56,074 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $169,316 | 64,379 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $225,630 | 63,918 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $197,515 | 63,921 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $270,335 | 63,909 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $152,416 | 64,311 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $184,522 | 64,745 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $186,312 | 64,692 | Shares | Defined | 2022-05-13 | |
| 2020-09-30 | $128,829 | 12,768 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $514,908 | 49,368 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $1,037,005 | 122,868 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||